Tag: WHO
MSIF’s work on access to MS healthcare
Addressing barriers to accessing MS healthcare at a global, regional and national level.
Relevant publications
Publications from MSIF and other stakeholders in support of work on access to MS healthcare.
The WHO Intersectoral Global Action Plan for epilepsy and other neurological disorders
A 10-year global action plan that aims to improve the lives of people living with neurological conditions including MS
WHO’s decision brings hope to people with MS worldwide
Multiple Sclerosis (MS) treatments added to WHO’s Essential Medicines List for the first time
MSIF emphasises need for treatments for neurological conditions during WHO meeting
MSIF and neurological organisations' statement during the Essential Medicines List Committee open session
Essential medicines for MS
Advocating for the addition of MS treatments to the WHO Essential Medicines List
Our application to the Essential Medicines List
Efforts to improve access to MS treatments continue
Improving access to MS treatment and healthcare
Addressing barriers to accessing treatment at a global, regional and national level
10-year Intersectoral global plan approved to improve care for people affected by neurological conditions
MSIF supports the adoption of the WHO's intersectoral global action plan on epilepsy and other neurological disorders, including MS
The MSIF movement shapes the WHO’s global action plan for epilepsy and other neurological disorders
MSIF highlights priority actions for MS in the draft global plan